TyraTech, Inc. (AIM: TYR), a natural life sciences company, provides the following information in connection with its block admission pursuant to AIM Rule 29 and Schedule Six of the AIM Rules:
Name of company: | TyraTech, Inc. |
Name of scheme: | 2007 Equity Compensation Plan of the Company |
Period of return: | From: 17 December 2012 To: 18 June 2013 |
Number and class of securities not issued under the scheme |
5,164,996 common shares |
Number of securities issued under the scheme during the period |
Nil |
Balance under the scheme of securities not yet issued at the end of the period |
5,164,996 common shares |
Number and class of securities originally admitted and the date of admission |
5,183,746 common shares on 2 March 2011 |
Name of contact: | Daniel Williams |
Telephone number of contact: | +1 919 415 4285 |
For further information please contact:
TyraTech Inc. Alan Reade, Executive Chairman Bruno Jactel, Chief Executive Officer |
Tel: +1 919 415 4310 Tel: +1 919 415 4280 |
N+1 Singer, Nominated Adviser and Joint Broker Aubrey Powell / Alex Wright |
Tel: +44 20 7496 3000 |
First Columbus LLP, Joint Broker Chris Crawford |
Tel: +44 20 3002 2070 |
Walbrook, Financial PR and IR Bob Huxford /Guy McDougall (Public Relations) Paul Cornelius (Investor Relations) |
Tel: +44 20 7933 8792 Tel: +44 20 7933 8794 |
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.